The Rezūm System

Clinical Data

The Results

Convective RF Water Vapor Therapy using the Rezūm® System has been studied in first-in-man (FIM) and Pilot Clinical Trials, as well as in a U.S. IDE Pivotal Trial. Enrollment in the studies is complete and patients will continue to be followed.

our goal: changing lives

Question about Rezūm?

Personal

NxThera’s founder, Michael Hoey, lost his father to prostate cancer in 1995. NxThera’s products are being designed to honor his memory. Michael is personally and passionately dedicated to finding humane and effective treatments for prostate and other endourologic conditions.

Innovative

RF energy is applied to convert sterile water to stored thermal energy in the form of vapor, which is convectively delivered to prostate tissue to treat benign prostatic hyperplasia (BPH), and has the potential to be used to treat prostate cancer and kidney cancer in future applications. NxThera's Convective RF Water Vapor Thermal Therapy technology has been studied in several BPH clinical trials and is designed to be a next generation minimally invasive treatment platform for a variety of endourologic conditions.